Abbott ABT Diagnostic Products — Net Sales
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's diagnostic products — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's diagnostic products — net sales?
- Abbott (ABT) reported diagnostic products — net sales of $2.18B in Q1 2026.
- How has Abbott's diagnostic products — net sales changed year-over-year?
- Abbott's diagnostic products — net sales increased by 6.1% year-over-year, from $2.05B to $2.18B.
- What is the long-term trend for Abbott's diagnostic products — net sales?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — net sales has grown at a -12.9% compound annual growth rate (CAGR), from $15.53B to $8.94B.
- What does diagnostic products — net sales mean?
- Total revenue earned from the diagnostics business segment.
- How do you interpret diagnostic products — net sales?
- An increase indicates growing market share or higher demand for diagnostic testing, while a decrease may signal market saturation or loss of competitive positioning.
- How does diagnostic products — net sales compare across companies?
- Standard revenue metric across all medical device and diagnostics peers.